<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03292081</url>
  </required_header>
  <id_info>
    <org_study_id>14-106</org_study_id>
    <nct_id>NCT03292081</nct_id>
  </id_info>
  <brief_title>Comparison Between OFDI and IVUS in PCI Guidance for Biolimus A9 Eluting Stent Implantation</brief_title>
  <acronym>MISTIC-1</acronym>
  <official_title>Comparison Between Optical Frequency Domain Imaging and Intravascular Ultrasound in Percutaneous Coronary Intervention Guidance for Biolimus A9 Eluting Stent Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fujita Health University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fujita Health University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess clinical safety and efficacy of percutaneous coronary
      intervention (PCI) using a newer generation drug-eluting stent (DES) in the context of
      optical frequency domain imaging (OFDI) guidance or intravascular ultrasound (IVUS) guidance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intracoronary imaging techniques provide clinically useful information in the setting of PCI,
      such as lesion severity, tissue characterization, vessel sizing, and stent optimization.
      Current evidences suggest potential advantage of intracoronary imaging guidance in reducing
      the risk of major adverse cardiac events after stent implantation over conventional PCI under
      angiographic guidance alone. IVUS has been clinically used in two decades and it is known as
      one of the most dominant intracoronary imaging technique. OFDI is a new light-based
      intracoronary imaging technology which provides higher image resolution and higher-speed
      pullback compared to those of IVUS. Given the different properties between ultrasound-based
      IVUS and light-based OFDI, treatment and clinical impact of these two imaging techniques
      would be different.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 12, 2014</start_date>
  <completion_date type="Anticipated">October 25, 2017</completion_date>
  <primary_completion_date type="Actual">July 31, 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Minimum lumen area assessed by OFDI</measure>
    <time_frame>8 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel myocardial infarction</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularization</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apposition of stent struts assessed by OFDI</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tissue coverage of stent struts assessed by OFDI</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative Coronary Angiography (QCA)</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Integrated Backscatter IVUS (IB-IVUS)</measure>
    <time_frame>0 month (pre-procedure)</time_frame>
    <description>Plaque components including lipid pool, fibrosis, dense fibrosis or calcification</description>
  </other_outcome>
  <other_outcome>
    <measure>Detectable external elastic lamina (EEL) arc assessed by OFDI</measure>
    <time_frame>0 month (pre-procedure)</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>OFDI-guided PCI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>IVUS-guided PCI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OFDI</intervention_name>
    <description>PCI under OFDI guidance</description>
    <arm_group_label>OFDI-guided PCI</arm_group_label>
    <other_name>LUNAWAVE imaging console</other_name>
    <other_name>Fastview imaging catheter</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IVUS</intervention_name>
    <description>PCI under IVUS guidance</description>
    <arm_group_label>IVUS-guided PCI</arm_group_label>
    <other_name>VISIWAVE imaging console</other_name>
    <other_name>ViewIT imaging catheter</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with stable coronary artery disease who have symptoms or myocardial ischemia
             proven by non-invasive or invasive stress test.

        Exclusion Criteria:

          -  Renal insufficiency with estimated glomerular filtration rate (eGFR) &lt;45 mL/min/1.73m2

          -  Left ventricular ejection fraction (LVEF) &lt;30% or history of congestive heart failure

          -  Acute coronary syndrome within 7 days after onset

          -  Considered as inappropriate for drug-eluting stent (DES) use or dual antiplatelet
             therapy for one year after the index procedure

          -  Life expectancy within one year

          -  Lesion length estimated by quantitative coronary angiography (QCA) &gt;28mm

          -  Chronic total occlusion

          -  Left main stem lesion

          -  Bifurcation requiring side branch balloon dilatation

          -  Severely calcified lesion

          -  Other conditions by which physicians in charge judged inappropriate to enroll the
             patients because of safety concern.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fujita Health University</name>
      <address>
        <city>Toyoake</city>
        <zip>470-1192</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2017</study_first_submitted>
  <study_first_submitted_qc>September 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2017</study_first_posted>
  <last_update_submitted>September 22, 2017</last_update_submitted>
  <last_update_submitted_qc>September 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fujita Health University</investigator_affiliation>
    <investigator_full_name>Yukio Ozaki</investigator_full_name>
    <investigator_title>Professor, Department of Cardiology</investigator_title>
  </responsible_party>
  <keyword>Intracoronary Imaging</keyword>
  <keyword>Optical Frequency Domain Imaging</keyword>
  <keyword>Intravascular Ultrasound</keyword>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <keyword>Drug Eluting Stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Umirolimus</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

